• Users Online: 192
  • Print this page
  • Email this page
Ahead of Print

Gene therapy for retinitis pigmentosa

 Department of Ophthalmology, School of Medicine, Saint Louis University, St. Louis, MO, USA

Correspondence Address:
Niloofar Piri,
1225 S Grand Blvd, Saint Louis, MO, 63104
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/tjo.tjo_47_21

Rhodopsin-mediated autosomal dominant retinitis pigmentosa (RP) is the most common cause of RP in North America. There is no proven cure for the disease, and multiple approaches are being studied. Gene therapy is an evolving field in medicine and ophthalmology. In this review, we will go over the basic concept of gene therapy and the different types of gene therapy that are currently being studied to treat this disease.

Print this article
  Search Pubmed for
    -  Piri N
    -  Grodsky JD
    -  Kaplan HJ
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded1    

Recommend this journal